Infliximab for moderate to severe ulcerative colitis: The jury isn't in yet

Research output: Contribution to journal › Letter

Cite this

@article{164d59bf52a14b5eb0da0388b125289e,

title = "Infliximab for moderate to severe ulcerative colitis: The jury isn't in yet",

author = "Nagesh Kamath and Asha Kamath and Pai, {C. Ganesh}",

year = "2014",

doi = "10.1053/j.gastro.2014.02.060",

language = "English",

volume = "147",

pages = "544--545",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Infliximab for moderate to severe ulcerative colitis

T2 - The jury isn't in yet

AU - Kamath, Nagesh

AU - Kamath, Asha

AU - Pai, C. Ganesh

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904620026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904620026&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2014.02.060

DO - 10.1053/j.gastro.2014.02.060

M3 - Letter

C2 - 24973682

AN - SCOPUS:84904620026

VL - 147

SP - 544

EP - 545

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -